Literature DB >> 6282941

Determination of specific IGA antibodies to varicella zoster virus by immunoperoxidase assay.

H Haikin, I Sarov.   

Abstract

An indirect peroxidase technique was developed for determination of IgA antibodies to varicella zoster virus (VZV). The antigen consisted of acetone-fixed trypsinised VZV-infected cells. Rabbit antihuman IgA peroxidase conjugate was used to detect human IgA antibodies bound to viral antigen. In parallel IgG antibodies to VZV were determined by an immunoperoxidase antibody to membrane antigen (IPAMA) technique. Varicella zoster virus IgA antibodies were detected in all five varicella and seven zoster patients. No VZV IgA antibodies (less than 2) were detected in 45 healthy control sera. Neither were they found in paired sera of five patients with herpes simplex infection, five patients with human cytomegalovirus infection and two patients with Epstein-Barr virus infection. Application of immunoperoxidase IgA technique in serodiagnosis of primary and reactivated VZV infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282941      PMCID: PMC497742          DOI: 10.1136/jcp.35.6.645

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  33 in total

1.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

2.  Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster.

Authors:  P A Brunell; A A Gershon; S A Uduman; S Steinberg
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

3.  A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections.

Authors:  E Lycke; R Norrby; B E Roos
Journal:  Br J Psychiatry       Date:  1974-03       Impact factor: 9.319

4.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

5.  Persistence of rubellavirus-specific immunoglobulin M and immunoglobulin A antibodies: investigation of successive serum samples with lowered immunoglobulin G concentration.

Authors:  A Hornsleth; J Leerhoy; P Grauballe; H Spanggaard
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

6.  Neutralizing antibody responses to varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

7.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

8.  Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans.

Authors:  N J Schmidt; B Forghani; E H Lennette
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

9.  Solid-phase radioimmunoassay of human immunoglobulin M and immunoglobulin G antibodies against herpes simplex virus type 1 capsid, envelope, and excreted antigens.

Authors:  K O Kalimo; R J Marttila; K Granfors; M K Viljanen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Specific IgM antibody in serum of patients with herpes zoster infections.

Authors:  C A Ross; R McDaid
Journal:  Br Med J       Date:  1972-12-02
View more
  3 in total

1.  Inhibition of growth of Chlamydia trachomatis by human gamma interferon.

Authors:  Y Shemer; I Sarov
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

2.  Antibody class capture assays for varicella-zoster virus.

Authors:  B Forghani; C K Myoraku; K W Dupuis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

3.  Fate of Chlamydia trachomatis in human monocytes and monocyte-derived macrophages.

Authors:  E Manor; I Sarov
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.